109 related articles for article (PubMed ID: 9142213)
1. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
[TBL] [Abstract][Full Text] [Related]
2. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
[TBL] [Abstract][Full Text] [Related]
3. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
[TBL] [Abstract][Full Text] [Related]
4. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
Vu TH; Hoffman AR
Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
[TBL] [Abstract][Full Text] [Related]
5. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
7. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor 2 gene.
Feil R; Handel MA; Allen ND; Reik W
Dev Genet; 1995; 17(3):240-52. PubMed ID: 8565330
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level.
Sohda T; Yun K; Iwata K; Soejima H; Okumura M
Lab Invest; 1996 Sep; 75(3):307-11. PubMed ID: 8804354
[TBL] [Abstract][Full Text] [Related]
9. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.
Harris TM; Rogler LE; Rogler CE
Oncogene; 1998 Jan; 16(2):203-9. PubMed ID: 9464538
[TBL] [Abstract][Full Text] [Related]
11. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
Wu HK; Squire JA; Song Q; Weksberg R
Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
[TBL] [Abstract][Full Text] [Related]
12. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
13. Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.
Li X; Gray SG; Flam F; Pietsch T; Ekström TJ
Int J Dev Biol; 1998 Jul; 42(5):687-93. PubMed ID: 9712523
[TBL] [Abstract][Full Text] [Related]
14. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
15. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
[TBL] [Abstract][Full Text] [Related]
17. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
19. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
[TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of genomic imprinting of the IGF2 gene in human liver.
Davies SM
Cancer Res; 1994 May; 54(10):2560-2. PubMed ID: 8168079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
